External validation of SCORE2-Diabetes risk prediction model in Chinese patients with diabetes
With the appropriate selection of the scaling factor, SCORE2-Diabetes shows satisfactory discrimination and calibration in Chinese, indicating its good generalisability. According to the latest guideline, the risk assessment in this real-world population indicated a significant demand for medications with cardiovascular efficacy and a substantial burden for lipid management.
Authors
- Xun Tang (ORCID: https://orcid.org/0000-0002-6990-0168)
- Jingyuan Liang (ORCID: https://orcid.org/0000-0002-3489-5776)
- Zhangping Fu (ORCID: https://orcid.org/0000-0003-4050-6260)
- Pei Gao (ORCID: https://orcid.org/0000-0001-8649-1290)
- Qi Chen (ORCID: https://orcid.org/0000-0003-3773-4641)
- Xiaofei Liu (ORCID: https://orcid.org/0000-0001-7524-485X)
- Hongbo Lin (ORCID: https://orcid.org/0000-0002-9953-4752)
- Peng Shen (ORCID: https://orcid.org/0000-0002-0176-127X)
- Yexiang Sun (ORCID: https://orcid.org/0000-0002-7500-7587)
Institutions
- King University (US)
- Peking University (CN)
- Clinical Research Institute (US)
- Ministry of Education (RO)
- Ningbo Center for Disease Control and Prevention (CN)
- National Center for Chronic Disease Prevention and Health Promotion (US)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1093/eurjpc/zwaf226
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47